HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice.

Abstract
The metabolic syndrome (visceral obesity, insulin resistance, type 2 diabetes, and dyslipidemia) resembles Cushing's Syndrome, but without elevated circulating glucocorticoid levels. An emerging concept suggests that the aberrantly elevated levels of the intracellular glucocorticoid reamplifying enzyme 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD-1) found in adipose tissue of obese humans and rodents underlies the phenotypic similarities between idiopathic and "Cushingoid" obesity. Transgenic overexpression of 11 beta-HSD-1 in adipose tissue reproduces a metabolic syndrome in mice, whereas 11 beta-HSD-1 deficiency or inhibition has beneficial metabolic effects, at least on liver metabolism. Here we report novel protective effects of 11 beta-HSD-1 deficiency on adipose function, distribution, and gene expression in vivo in 11 beta-HSD-1 nullizygous (11 beta-HSD-1(-/-)) mice. 11 beta-HSD-1(-/-) mice expressed lower resistin and tumor necrosis factor-alpha, but higher peroxisome proliferator-activated receptor-gamma, adiponectin, and uncoupling protein-2 mRNA levels in adipose, indicating insulin sensitization. Isolated 11 beta-HSD-1(-/-) adipocytes exhibited higher basal and insulin-stimulated glucose uptake. 11 beta-HSD-1(-/-) mice also exhibited reduced visceral fat accumulation upon high-fat feeding. High-fat-fed 11 beta-HSD-1(-/-) mice rederived onto the C57BL/6J strain resisted diabetes and weight gain despite consuming more calories. These data provide the first in vivo evidence that adipose 11 beta-HSD-1 deficiency beneficially alters adipose tissue distribution and function, complementing the reported effects of hepatic 11 beta-HSD-1 deficiency or inhibition.
AuthorsNicholas M Morton, Janice M Paterson, Hiroaki Masuzaki, Megan C Holmes, Bart Staels, Catherine Fievet, Brian R Walker, Jeffrey S Flier, John J Mullins, Jonathan R Seckl
JournalDiabetes (Diabetes) Vol. 53 Issue 4 Pg. 931-8 (Apr 2004) ISSN: 0012-1797 [Print] United States
PMID15047607 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Glucose
  • Insulin
  • Ion Channels
  • Membrane Transport Proteins
  • Mitochondrial Proteins
  • Receptors, Cytoplasmic and Nuclear
  • Transcription Factors
  • Triglycerides
  • UCP2 protein, human
  • Ucp2 protein, mouse
  • Uncoupling Protein 2
  • Cholesterol
  • 11-beta-Hydroxysteroid Dehydrogenase Type 1
Topics
  • 11-beta-Hydroxysteroid Dehydrogenase Type 1 (deficiency, genetics, physiology)
  • Adipocytes (drug effects, physiology)
  • Adipose Tissue (physiology)
  • Animals
  • Blood Glucose (drug effects, metabolism)
  • Body Temperature
  • Body Weight
  • Cholesterol (metabolism)
  • Diet
  • Gene Expression Regulation
  • Glucose Tolerance Test
  • Insulin (pharmacology)
  • Ion Channels
  • Male
  • Membrane Transport Proteins (genetics)
  • Mice
  • Mice, Knockout
  • Mitochondrial Proteins (genetics)
  • Obesity (genetics, prevention & control)
  • Receptors, Cytoplasmic and Nuclear (genetics)
  • Transcription Factors (genetics)
  • Triglycerides (metabolism)
  • Uncoupling Protein 2

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: